Many manufacturers design their operations around large production runs, but Lady Burd appears to have intentionally structured its model to support small startups while still being capable of scaling for larger brands
The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity
PlexusDx patients can access Precision Peptide Genetic Testing to identify individual predispositions in glucose metabolism pathways, allowing providers to anticipate and prevent metabolic complications
Third, MR estimates, although less confounded, are less precise than conventional observational studies, because the genetic variants only explain a small proportion of the variance in exposure [38]